» Articles » PMID: 37255310

Nonlinear Data Fusion over Entity-Relation Graphs for Drug-Target Interaction Prediction

Overview
Journal Bioinformatics
Specialty Biology
Date 2023 May 31
PMID 37255310
Authors
Affiliations
Soon will be listed here.
Abstract

Motivation: The prediction of reliable Drug-Target Interactions (DTIs) is a key task in computer-aided drug design and repurposing. Here, we present a new approach based on data fusion for DTI prediction built on top of the NXTfusion library, which generalizes the Matrix Factorization paradigm by extending it to the nonlinear inference over Entity-Relation graphs.

Results: We benchmarked our approach on five datasets and we compared our models against state-of-the-art methods. Our models outperform most of the existing methods and, simultaneously, retain the flexibility to predict both DTIs as binary classification and regression of the real-valued drug-target affinity, competing with models built explicitly for each task. Moreover, our findings suggest that the validation of DTI methods should be stricter than what has been proposed in some previous studies, focusing more on mimicking real-life DTI settings where predictions for previously unseen drugs, proteins, and drug-protein pairs are needed. These settings are exactly the context in which the benefit of integrating heterogeneous information with our Entity-Relation data fusion approach is the most evident.

Availability And Implementation: All software and data are available at https://github.com/eugeniomazzone/CPI-NXTFusion and https://pypi.org/project/NXTfusion/.

Citing Articles

BindingSiteDTI: differential-scale binding site modelling for drug-target interaction prediction.

Pan F, Yin C, Liu S, Huang T, Bian Z, Yuen P Bioinformatics. 2024; 40(5).

PMID: 38730554 PMC: 11256917. DOI: 10.1093/bioinformatics/btae308.


A comparison of embedding aggregation strategies in drug-target interaction prediction.

Iliadis D, De Baets B, Pahikkala T, Waegeman W BMC Bioinformatics. 2024; 25(1):59.

PMID: 38321386 PMC: 10845509. DOI: 10.1186/s12859-024-05684-y.

References
1.
Ozturk H, Ozgur A, Ozkirimli E . DeepDTA: deep drug-target binding affinity prediction. Bioinformatics. 2018; 34(17):i821-i829. PMC: 6129291. DOI: 10.1093/bioinformatics/bty593. View

2.
Cichonska A, Ravikumar B, Allaway R, Wan F, Park S, Isayev O . Crowdsourced mapping of unexplored target space of kinase inhibitors. Nat Commun. 2021; 12(1):3307. PMC: 8175708. DOI: 10.1038/s41467-021-23165-1. View

3.
Wen M, Zhang Z, Niu S, Sha H, Yang R, Yun Y . Deep-Learning-Based Drug-Target Interaction Prediction. J Proteome Res. 2017; 16(4):1401-1409. DOI: 10.1021/acs.jproteome.6b00618. View

4.
Liu H, Sun J, Guan J, Zheng J, Zhou S . Improving compound-protein interaction prediction by building up highly credible negative samples. Bioinformatics. 2015; 31(12):i221-9. PMC: 4765858. DOI: 10.1093/bioinformatics/btv256. View

5.
Mistry J, Bateman A, Finn R . Predicting active site residue annotations in the Pfam database. BMC Bioinformatics. 2007; 8:298. PMC: 2025603. DOI: 10.1186/1471-2105-8-298. View